Sandra Jean Ingleton, a former mayor of Louth, England, who died at 77 and who had long lived with multiple sclerosis, donated her body to the Multiple Sclerosis Society Tissue Bank to support research. "She decided about 10 years ago that she would donate her body to science, as her father also had MS and he did the same," said Phillip Ingleton, her husband.
The eye banking world refers to the journey that tissue makes from donor to recipient as the "cycle of giving," writes Diane Hollingsworth, executive director of Illinois Operations of Eversight. Advances in state policies and in the field of eye banking have made corneal transplants the most common form of transplant, Hollingsworth writes.
Xenetic Biosciences reported that a Phase I/II study of Shire's SHP656 hemophilia A treatment candidate missed the study's goal of establishing weekly dosing.
Three clinical trials will be launched between July 2017 and early 2018 in a joint venture between Genmab and Janssen Biotech to test the efficacy of Janssen's drug Darzalex, or daratumumab, in patients with multiple myeloma. The planned trials -- two Phase III and one Phase II -- "emphasize the commitment to test daratumumab broadly in many different clinical settings, which hopefully results in better treatment options for patients," said Genmab CEO Jan van de Winkel.
Tedros Adhanom, a former health minister of Ethiopia, has been elected director-general of the World Health Organization and will succeed Dr. Margaret Chan on July 1. "I will exercise this legitimacy to bring the change and reform we need for this noble organisation to reclaim its trust from member states and from every citizen of the world," Tedros said.
The Office of the National Coordinator for Health IT and the CDC are developing a system to facilitate electronic sharing of Zika virus testing data between laboratories and health care providers. The project will use a web portal for providers and Health Level Seven's Fast Healthcare Interoperability Resources standard, said Michelle Meigs of the Association of Public Health Laboratories, which is also a partner on the project.
Biotech company Sangamo Therapeutics will conduct three clinical trials, which will focus on hemophilia B and Hunter and Hurler syndromes, to test the efficacy of in vivo human genome editing through the use of zinc finger nucleases. "This is the first time someone could have a new gene put into their liver," said Sangamo President and CEO Sandy Macrae.
A study published in the journal Nature Communications found that a single bite from an Aedes aegypti mosquito can transmit the Zika, dengue and chikungunya viruses. Researchers with Colorado State University said coinfections may be underdiagnosed.
An increasing number of travelers coming back from international destinations may have Clostridium difficile infections, according to a study in the Journal of Travel Medicine that looked at 187 cases. The analysis of GeoSentinel records identified nine infections in 1997, compared with 31 in 2006 and 56 in 2015.
Health officials from the G-20 nations assembled in Germany to focus on the rising number of pathogens that are becoming resistant to antibiotics. "By putting global health on the agenda of the G-20, we affirm our role in strengthening the political support for existing initiatives and working to address the economic aspects of global health issues," the health ministers said in a communique.
- Page 1